Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Aug;77(2):226–229.

Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.

P E Fine 1, P J Gruer 1, N Maine 1, J M Ponnighaus 1, R J Rees 1, J L Stanford 1
PMCID: PMC1541994  PMID: 2673590

Abstract

In order to test a published claim that the inclusion of Mycobacterium leprae antigens with a tuberculin skin test reagent can suppress delayed-type hypersensitivity (DTH) to tuberculin in both paucibacillary and multibacillary leprosy cases, 109 leprosy cases and 104 non-leprosy controls were skin-tested simultaneously with tuberculin with and without M. leprae soluble antigens. Tests were randomized between arms and carried out double-blind. There was a clear tendency for larger DTH responses with the combined tuberculin plus M. leprae antigen than with tuberculin alone in paucibacillary leprosy cases and in non-leprosy controls. No evidence for M. leprae antigen-mediated suppression of DTH was observed in any group. It is unclear whether the difference between the results reported here, which were obtained in Malawi, and those in the published literature which were obtained in India, is attributable to geographic differences in important biological variables or to differences in the experimental protocols. The need for methodological rigour in skin-test studies is stressed.

Full text

PDF
226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom B. R., Mehra V. Immunological unresponsiveness in leprosy. Immunol Rev. 1984 Aug;80:5–28. doi: 10.1111/j.1600-065x.1984.tb00493.x. [DOI] [PubMed] [Google Scholar]
  2. Fine P. E. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev. 1982;4:161–188. doi: 10.1093/oxfordjournals.epirev.a036245. [DOI] [PubMed] [Google Scholar]
  3. Mehra V., Brennan P. J., Rada E., Convit J., Bloom B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature. 1984 Mar 8;308(5955):194–196. doi: 10.1038/308194a0. [DOI] [PubMed] [Google Scholar]
  4. Mehra V., Mason L. H., Fields J. P., Bloom B. R. Lepromin-induced suppressor cells in patients with leprosy. J Immunol. 1979 Oct;123(4):1813–1817. [PubMed] [Google Scholar]
  5. Nath I., Van Rood J. J., Mehra N. K., Vaidya M. C. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Clin Exp Immunol. 1980 Nov;42(2):203–210. [PMC free article] [PubMed] [Google Scholar]
  6. Ponnighaus J. M., Fine P. E., Bliss L. Certainty levels in the diagnosis of leprosy. Int J Lepr Other Mycobact Dis. 1987 Sep;55(3):454–462. [PubMed] [Google Scholar]
  7. Ponnighaus J. M., Fine P. E., Maine N., Bliss L., Kalambo M., Ponnighaus I. The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in northern Malaŵi. II: Prevalence rates. Lepr Rev. 1988 Jun;59(2):97–112. doi: 10.5935/0305-7518.19880014. [DOI] [PubMed] [Google Scholar]
  8. Ponninghaus J. M., Fine P. E., Bliss L., Sliney I. J., Bradley D. J., Rees R. J. The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malaŵi. I. Methods. Lepr Rev. 1987 Dec;58(4):359–375. doi: 10.5935/0305-7518.19870038. [DOI] [PubMed] [Google Scholar]
  9. Rea T. H. Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy. Clin Exp Immunol. 1983 Nov;54(2):298–304. [PMC free article] [PubMed] [Google Scholar]
  10. Sengupta U., Sinha S., Ramu G., Lamb J., Ivanyi J. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy. Clin Exp Immunol. 1987 Apr;68(1):58–64. [PMC free article] [PubMed] [Google Scholar]
  11. Smelt A. H., Rees R. J., Liew F. Y. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol. 1981 Jun;44(3):501–506. [PMC free article] [PubMed] [Google Scholar]
  12. Stanford J. L., Lema E. The use of a sonicate preparation of Mycobacterium tuberculosis (new tuberculin) in the assessment of BCG vaccination. Tubercle. 1983 Dec;64(4):275–282. doi: 10.1016/0041-3879(83)90024-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES